Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstituto do Cancer do Estado de São Paulo

About this trial

CONSTELAR is a prospective, single-arm, multi-specialty registry designed to evaluate the safety and intraoperative performance of the RonovoTM robotic surgical platform in adult patients undergoing elective oncological surgery. The study enrolls patients across four surgical specialties (Digestive Surgery, Thoracic Surgery, Urology, and Gynecology) at a single academic center. Primary endpoints include 30-day and 90-day complication rates (Clavien-Dindo classification), operative times, conversion rates, estimated blood loss, and device-related technical failures. Secondary endpoints encompass length of hospital stay, Intensive Care Unit (ICU) admission, readmission/reoperation rates, and oncological surgical outcomes (resection margins, lymph node harvest). The study aims to provide initial safety and feasibility data to support the regulatory pathway for the RonovoTM platform in Latin America.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Confirmed malignancy diagnosis

Elective indication for robotic approach using RonovoTM

Able to understand and sign informed consent

Disqualifiers

Formal contraindication to minimally invasive surgery

Severe comorbidity prohibiting the procedure

Refusal to participate or sign informed consent

Emergency surgery

Trial design

Treatments tested in this trial

  • RonovoTM Robotic Surgical Platform

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Instituto do Cancer do Estado de São Paulo

Lead sponsor

Ronovo (Shanghai) Medical Science and Technology Ltd

Collaborator